Actinium Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Actinium Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 92% to $81,000. Profit margin reached -60269%. Total operating expenses were $52,001,000.
Profit Margin
| 2014 | 0 | -24.68M | |
|---|---|---|---|
| 2015 | 0 | -21.02M | |
| 2016 | 0 | -24.32M | |
| 2017 | 0 | -26.60M | |
| 2018 | 0 | -23.65M | |
| 2019 | 0 | -21.72M | |
| 2020 | 0 | -22.03M | |
| 2021 | 1.14M | -24.58M | -2148.95% |
| 2022 | 1.03M | -31.93M | -3100% |
| 2023 | 81K | -48.81M | -60269.14% |
ATNM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 81K | 1.03M | 1.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 699K | 524K | 447K | 420.08K | 0 | 55.93K | 0 | 53.46K | 0 |
Gross profit | 81K | 331K | 620K | -447K | -420.08K | 0 | -55.93K | 0 | -53.46K | 0 |
Operating exp. | ||||||||||
Research and development | 38.67M | 23.13M | 18.03M | 16.08M | 16.54M | 17.09M | 17.69M | 17.50M | 13.31M | 12.26M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 52.00M | 35.13M | 26.10M | 22.39M | 22.07M | 23.82M | 26.91M | 26.84M | 24.82M | 22.48M |
Operating income | -51.92M | -34.10M | -24.96M | -22.39M | -22.07M | -23.82M | -26.91M | -26.84M | -24.82M | -22.48M |
Other income (expenses), net | 3.10M | 1.08M | 190K | 178K | 172.39K | 173.35K | 309.55K | 2.53M | 3.80M | -2.20M |
Income before tax | -48.81M | -33.01M | -24.77M | -22.21M | -21.89M | -23.65M | -26.60M | -24.32M | -21.02M | -24.68M |
Income tax expense | 0 | -1.08M | -190K | -178K | -172.39K | 173.35K | -309.55K | 5.00K | 7.86K | 866 |
Net income | -48.81M | -31.93M | -24.58M | -22.03M | -21.72M | -23.65M | -26.60M | -24.32M | -21.02M | -24.68M |
Earnings per share | ||||||||||
Basic EPS | -1.83 | -1.32 | -1.2 | -1.82 | -4.37 | -6.69 | -11.96 | -15.06 | -16.53 | -27.07 |
Diluted EPS | -1.83 | -1.32 | -1.2 | -1.82 | -4.37 | -6.69 | -11.96 | -15.06 | -16.53 | -27.07 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |